EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned

K Laryionava, R Boekels, J Schildmann iD, M Wensing, U Wedding, B Surmann, K Mehlis, C Gebel, M Cinci, K Krug, E C Winkler iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von K Laryionava und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Medical Faculty Heidelberg, Section Translational Medical Ethics, National Center for Tumor Diseases, NCT Heidelberg,…. Hauptthemen laut MEDLINE: Neoplasms, Decision Support Techniques, Feasibility Studies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Krebshilfe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Decision aids (DAs) have been proposed as tools to empower patients in decision‐making. However, implementing DA for decisions in advanced cancer is challenging. This study focuses on perspectives of oncologists and other healthcare providers on the hindering and facilitating factors for implementing a customizable DA. This DA is designed to support discussions about whether patients with advanced, incurable cancers should pursue or forgo further anticancer treatment.

Methods

This qualitative study utilized content analysis following Sandelowski's approach on two different datasets derived from research projects on decision‐making in advanced cancer. To inform the development of a DA and understand challenges related to its implementation, we conducted semi‐structured interviews with 24 oncologists (Dataset 1) and three focus groups with various healthcare professionals ( n = 19) and in addition post‐implementation semi‐structured interviews with oncologists who used the DA in conversations with their cancer patients ( n = 5) (Dataset 2). Furthermore, the insights from process evaluation of developing and implementing the DA in an outpatients' settings was incorporated, enriching the analytical framework.

Results

Two overall themes emerged: (1) Tension between standardizing the use of a DA and responding to individual patient needs. To address this conflict, a two‐part DA was developed, combining structured elements with flexibility. (2) Prerequisites for the use of the DA in outpatients' settings: Senior physicians' support, education in palliative care options and in the use of the DA, and organizational conditions.

Conclusion

Oncologists identified both structural and content‐related aspects for a successful implementation of a DA for patients with advanced cancer. While the content‐related aspects were factored into the development of the DA, structural (organizational) issues need to be especially focused on during implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDecision Support TechniquesFeasibility StudiesHumansQualitative ResearchFemaleMaleCancer Care FacilitiesPatient ParticipationOutpatientsOncologistsFocus GroupsMiddle Aged

Stichwörter der Autor:innen

advanced cancerdecision aidforgoing of cancer treatmentimplementation researchqualitative study

Autor:innen und Institutionen

  • Department of Medical Oncology, Medical Faculty Heidelberg, Section Translational Medical Ethics, National Center for Tumor Diseases, NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidel…
  • Institute for History and Ethics of Medicine, Centre for Health Sciences, Martin Luther University Halle-Wittenberg (Saale), Halle (Saale), Germany.
  • Department of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Internal Medicine II (Palliative Care), University of Jena, Jena, Germany.
  • Health Economics and Health Care Management, Bielefeld University, Bielefeld, Germany.

ORCID-Profile: J Schildmann, E C Winkler

Förderung

  • Deutsche Krebshilfe

Zitieren

APA

Laryionava, K., Boekels, R., Schildmann, J., Wensing, M., Wedding, U., Surmann, B., Mehlis, K., Gebel, C., Cinci, M., Krug, K., & Winkler, E. C. (2024). Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned. Cancer Medicine. https://doi.org/10.1002/cam4.70127

Vancouver

Laryionava K, Boekels R, Schildmann J, Wensing M, Wedding U, Surmann B, et al. Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned. Cancer Medicine. 2024. doi:10.1002/cam4.70127

BibTeX
@article{Laryionava2024,
  author = {Laryionava, K and Boekels, R and Schildmann, J and Wensing, M and Wedding, U and Surmann, B and Mehlis, K and Gebel, C and Cinci, M and Krug, K and Winkler, E C},
  title = {Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70127}
}
Kostenlos starten →